Acceleration of HIV dementia with methamphetamine and cocaine (original) (raw)

References

• Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, Novakovic-Agopian T, Price RW (1999). Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol 20: 39–43.
  CAS PubMed Google Scholar
• Bell JE, Brettle RP, Chiswick A, Simmonds P (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIES. Effect of neocortical involvement. Brain 121: 2043–2052.
  Article PubMed Google Scholar
• Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B (1994). Cerebrospinal fluid dopamine in HIV-l infection. AIDS 8: 67–71.
  Article CAS PubMed Google Scholar
• Berger JR, Nath A (1997). HIV dementia and the basal ganglia. Intervirology 40: 122–131.
  Article CAS PubMed Google Scholar
• Berger JR, Nath A, Greenberg RN, Andersen AH, Greene RA, Bognar A, Avison MJ (2000). Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 54: 921–926.
  CAS PubMed Google Scholar
• Bouwman FH, Skolasky RL, Hes D, Scines OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998). Variable progression of HIV-associated dementia. Neurology 50: 1814–1820.
  CAS PubMed Google Scholar
• Concha M, Graham NM, Munoz A, Vlahov D, Royal WD, Updike M, Nance-Sproson T, Scines OA, McArthur JC (1992). Effect of chronic substance abuse on the neuropyschological performance of intravenous drug users with a high prevalence of HIV-l seropositivity. Am J Epidemiol 136: 1338–1348.
  CAS PubMed Google Scholar
• Concha M, Scines OA, Vlahov D, Nance-Sproson T, Updike M, Royal W, Palenicek J, McArthur JC (1997). Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. Neuroepidemiology 16: 78–85.
  Article CAS PubMed Google Scholar
• Ernst T, Chang L, Leonido-Yee M, Speck O (2000). Evidence of long term neurotoxicity associated with methamphetamine abuse. A 1H MRS study. Neurology 54: 1344–1349.
  CAS PubMed Google Scholar
• Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, Shapshak P, Stins M, Kim KS, Witte M, Chang SL (1998). Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine’s connection to AIDS dementia and vasculitis? Adv Exp Med Biol 437: 199–205.
  CAS PubMed Google Scholar
• Fujimura RK, Goodkin K, Petito CK, Douyon R, Feaster DJ, Concha M, Shapshak P (1997). HIV-l proviral DNA load across neuroanatomic regions of individuals with evidence for HTV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol 16: 146–152.
  CAS PubMed Google Scholar
• Gendelman H, Zheng J, Coulter C, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Swindells S (1998). The HIV-associated dementia complex: a metabolic encephalopathy reversed by highly active antiretroviral therapy. J Infect Dis 178: 1000–1007.
  Article CAS PubMed Google Scholar
• Grassi MP, Perin C, Clerici F, Zocchetti C, Borella M, Cargnel A, Mangoni A (1997). Effects of HIV seropositivity and drug abuse on cognitive function. Eur Neurol 37: 48–52.
  Article CAS PubMed Google Scholar
• Harrison MB, Lyons GR, Landow ER (1993). Phenytoin and dyskinesias: a report of two cases and review of the literature. Mov Disord 8: 19–27.
  Article CAS PubMed Google Scholar
• Hayman M, Arbuthnott G, Harkiss G, Brace H, Filippi P, Philippon V, Thomson D, Vigne R, Wright A (1993). Neurotoxicity of peptide analogues of the transactivating protein tat from Maedia-Visna virus and human immunodeficiency virus. Neuroscience 53: 1–6.
  Article CAS PubMed Google Scholar
• Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM (1994). Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 54: 19–28.
  Article CAS PubMed Google Scholar
• Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A (1998). Intraventricular injection of human immunodeficiency virus type 1 (HTV-l) Tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 57: 563–570.
  Article CAS PubMed Google Scholar
• Kruman II, Nath A, Maragos WF, Chan SL, Jones M, Rangnekar VM, Jakel RJ, Mattson MP (1999). Evidence that Par-4 participates in the pathogenesis of AIDS dementia. Am J Pathol 155: 39–46.
  CAS PubMed Google Scholar
• Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999). Evidence of active nerve cell degeneration in the substantia nigra of humans years after l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine exposure. Ann Neurol 46: 598–605.
  Article CAS PubMed Google Scholar
• Larsson M, Hagberg L, Foreman A, Norkrans G (1991). Cerebrospinal fluid catecholamine metabolites in hIV-infected patients. J Neurosci Res 28: 406–409.
  Article CAS PubMed Google Scholar
• Nath A, Conant K, Chen P, Scott C, Major EO (1999). Transient exposure to HIV-l Tat protein results in cytokine production in macrophages and astrocytes: A hit and run phenomenon. J Biol Chem 274: 17098–17102.
  Article CAS PubMed Google Scholar
• Nath A, Geiger JD (1998). Neurobiological aspects of HIV infections: neurotoxic mechanisms. Prog Neurobiol 54: 19–33.
  Article CAS PubMed Google Scholar
• Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47: 186–194.
  Article CAS PubMed Google Scholar
• Nath A, Jones M, W, M, Booze RM, Mactutus C, Bell J, Mattson M (2000). Neurotoxicity and E)ysfunction of Eopaminergic Systems Associated with AIDS Dementia. J Psychopharmacology (in press).
• Navia BA, Cho ES, Petiio CK, Price RW (1986). The AIDS dementia complex: II Neuropathology. Ann Neurol 19, 525–535.
  Article CAS PubMed Google Scholar
• Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643–4649.
  CAS PubMed Google Scholar
• Power C, Scines OA, Grim JA, McArthur JC (1995). HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8: 273–278.
  Article CAS PubMed Google Scholar
• Price RW, Brew BJ (1988). The AIDS dementia complex. J Infect Dis 158: 1079–1083.
  CAS PubMed Google Scholar
• Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K (1999). Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS 13: 1677–1685.
  Article CAS PubMed Google Scholar
• Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R (1991). Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 82: 39–44.
  Article CAS PubMed Google Scholar
• Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Scines OA, Becker JT, Cohen B, Wesch J, Miller EN (1999). Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 52: 1640–1647.
  CAS PubMed Google Scholar
• Sardar AM, Czudek C, Reynolds GP (1996). Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7: 910–912.
  Article CAS PubMed Google Scholar
• Scines OA, Galai N, McArthur JC, Cohn S, Royal W, 3rd, Esposito D, Vlahov D (1997). HIV infection and cognition in intravenous drug users: long-term follow-up. Neurology 48: 223–230.
  Google Scholar
• Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB, Ravert HT, Musachio J, McCann UD, Ricaurte GA (1998). Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18: 419–427.
  CAS PubMed Google Scholar
• Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996a). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699–703.
  Article CAS PubMed Google Scholar
• Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ (1996b). Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40: 428–439.
  Article CAS PubMed Google Scholar

Download references